Background/Aims: We investigated the regenerative capacity of intravenous administration of bone marrow-derived mononuclear cells (BMMCs) in a rat model of bilateral renal other biological markers in this process. Methods: Rats were subjected to 1h bilateral renal pedicle clamping. BMMCs were injected i.v 1h after reperfusion and tracked by 99m Tc and GFP+ BMMCs. Twenty-four hours after reperfusion, renal function and histological changes were evaluated. The mRNA (real time PCR) and protein (ELISA and immuno-staining) expression of biological markers were analyzed. Results: Renal function and structure improved after infusion of BMMCs in the IR group (IR-C). Labeled BMMCs were found in the kidneys after markers (IL-10, Nrf2, and HO-1) were increased in IR-C animals compared with IR untreated animals (IR-S). The apoptotic index diminished and the proliferation index increased in IR-C compared with IR-S. Conclusion: The results contribute to our understanding of the role of different biological players in morphofunctional renal improvement and cytoprotection in a post-ischemic reperfusion kidney injury model subjected to cellular therapy.
Introduction
Acute tubular necrosis (ATN) is the most common cause of acute renal failure in the hospital and in the intensive care unit; it occurs in 88% of all cases of acute kidney injury (AKI) and has high morbidity and mortality [1] . Ischemia/reperfusion injury (IRI) of renal allografts is also a form of ATN, and depending on its severity and duration results in nonfunctional grafts and delayed graft injury with long-term chronic renal ischemia and hypoxia [2] .
IRI is a complex event that involves injury caused by the metabolic changes induced by the depletion of adenosine triphosphate (ATP) and by reactive oxygen species (ROS) formed after reperfusion. Both tubular epithelial cells and endothelial cells are affected and die by apoptosis, necrosis, and autophagy-associated cell death [3] . Necrotic cells allow the escape of intracellular molecules such as ATP and high-mobility group box-1 (HMGB1), molecules receptors leading to the recruitment and activation of innate immune system cells. Recent in vivo in the context response observed when they are inhibited [4] .
Despite huge advances in knowledge on the pathophysiology of renal injury induced consequence of a series of biological processes elicited after the initial insult and subsequent host response. Repair mechanisms initiate the reparative response simultaneously with the process is spontaneously resolved with a decrease in damage biomarkers and a rapid return of renal function. Normal repair involves a complex network of growth factors, and proliferative and other signaling cascades, which must operate in a coordinated way and be temporally and spatially integrated [6] . The repair process is carried out by viable tubular renal cells that become dedifferentiated, re-express developmental programs, and migrate to the sites of cell loss, where they engraft and redifferentiate to regain polarity of tubular and vascular integrity and function [7] . However, when the injury is too severe, the regenerative capacity of the kidney is overwhelmed. To avoid the high morbidity and mortality seen in humans, alternative treatments have been proposed to halt and decrease vasoactive drugs and cytoprotective therapy among others [2] . Therefore, there is an urgent vascular, endothelial, and tubular regeneration. Therapeutic use of adult stem cells may be one of these innovative therapies. Cell-based therapy is a promising strategy for several pathological conditions, including severe acute or chronic kidney disease and is currently the focus of preclinical studies. The (secreted growth factors, microvesicles, and exosomes) seen in animal models of AKI have been translated into clinical trials. The administration of allogeneic mesenchymal stromal cells (MSCs) to patients undergoing open-heart surgery who are at high risk of acute renal failure was proven to be feasible and safe [10] . Moreover, in kidney transplant recipients, stem cell therapy improved regeneration, decreased the incidence of acute rejection episodes, and led to a better estimated renal function at 6 months or 1 year [11] .
Adult stem cells include bone marrow stem cells, comprising hematopoietic stem cells, [12] , subsequent studies demonstrated that the main therapeutic effects were mediated primarily through the secretion of soluble factors. As cell-based therapies based on bone and failures are now widely known. Despite their promising results to improve structural recovery, complete functional improvement has still not been achieved [13] [14] [15] . Different from other types of cell therapies, therapy with BMMCs consists of a mixture of lymphoid, monocytes, natural killer cells, and hematopoietic progenitor cells [16, 17] . However, BMMCs have the advantage of easy isolation and separation of adequate amounts of BMMCs from a Therefore, due to the broader regenerative properties of BMMCs, we hypothesized that cellular therapy can help accelerate renal morphofunctional recovery in a model of bilateral and apoptotic molecules.
Materials and Methods

Animal Model
and reperfusion treated with saline (IR-S), and ischemia and reperfusion treated with BMMC (IR-C). The animals that underwent IR injury were anesthetized with ketamine (150 mg/kg) and xylazine (10 mg/ kg) intraperitoneally, and injury was induced by clamping both renal pedicles for 1 h (bilaterally) with a microvascular non-traumatic clamp (Roca Instrumental, São Paulo, Brazil) through an abdominal incision. Sham animals were subjected to the same surgical procedure without clamping of the renal artery. solution was added to the cell suspension and the mixture was incubated at room temperature for 10 min. Then, 5mCi of Tc was added and incubated for more 10 min. After centrifugation (5000 × g for 5 min), the supernatant was removed, and the cells were activity in the pellet divided by the sum of radioactivity in the pellet plus supernatant, and was estimated 6 Tc-BMMCs were injected through the jugular vein immediately a dedicated small-animal Triumph II PET/SPECT/CT Imaging system (Gamma Medica-Ideas, Salem, NH) equipped with a high-resolution collimator and diagnostic computed tomography (CT) 2 and 4 h after Tc-BMMC administration.
GFP+ BMMCs. Due to the short half-life of Tc, which only allows tracking of injected BMMCs up to thick sections were re-cut to obtain a total of 15 sections for each kidney slice (a total of 30 histological 2 fragment of IgG conjugated
Renal function
potassium. Plasma and urinary creatinine concentrations were determined by a colorimetric method using picric acid (Gold Analisa Diagnóstica, São Paulo, Brazil). The results obtained from plasma and 24-h urine samples creatinine concentration)/plasma creatinine concentration).
2 ). The concentrations of sodium and potassium were determined in plasma and urine using commercial results obtained from plasma and urine were used to calculate the clearance of sodium and potassium concentration. The following formula was used to determine the fraction of sodium and potassium excreted in %) was used (sodium or potassium clearance/creatinine clearance) × 100. 
Real-time quantitative PCR
A quantitative real-time reverse transcription (RT) polymerase chain reaction (PCR) was performed to measure the relative levels of mRNA of tumor necrosis -ceptor for advanced glycation end products (RAGE), kidney injury Table 1 . Primer Sequences -cDNA was synthesized from total RNA using a QuantiTect Reverse Transcription Kit (QIAGEN). Real-time PCR primers for the target gene were purchased from Invitrogen (Carlsbad, CA). Relative mRNA levels were -dorf (Eppendorf, Hamburg, Germany). All experiments were performed in triplicate. The relative expression of each gene was calculated as a ratio of the gene under study to the control gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and expressed as fold change relative to control (2 ). The PCR primers used are listed in Table 1 .
Protein extraction and ELISA
The renal tissue was homogenized in lysis buffer (250 mM sucrose, 20 mM HEPES, 1 mM EDTA, 50
Mannheim, Germany). After homogenization, the tissue homogenate was centrifuged at 600 × g for 5 min, and the supernatant was transferred to a new tube and centrifuged again at 3000 × g for 10 min. Protein
Histological score for tubular injury group were captured randomly, and an average of 20 tubules were analyzed for tubular dilatation, apical cytoplasm vacuolization, cell detachment, brush border integrity, and denuded basement membrane and tubular necrosis, which characterizes proximal tubular injury. A lesion score was assigned in a blinded alterations affecting 10% of tubules or fewer; 3, alterations affecting 25% of tubules; 4, alterations affecting 50% of tubules; and 5, alterations in 75% or more tubules.
Immunohistochemistry
(AbDSerotec, Raleigh, NC); a mouse monoclonal antibody against proliferating cell nuclear antigen (PCNA) heme-oxigenase-1, and HMGB1 (AbCam, Cambridge, MA). After dewaxing and rehydrating, sections were submitted to endogenous peroxidase inhibition (15 min with 3% H 2 O 2 in methanol). Heat-mediated antigen was diaminobenzidine liquid (DakoCytomation). Negative control slides were incubated with mouse or rabbit isotype immunoglobulins or with the antibody diluent solution. Immunoreactivity to KIM-1 was seen in injured tubules in IR-S, with diminishing reactivity in IR-C, and density of KIM-1 immunoreactivity was decreased in the IR-C group compared with the IR-S group and was n of IR-S compared with all other groups (P < 0.05). † and S-C (P < 0.05). other groups (P > 0.05) and that there was decrease in the amount of KIM-1 in the IR-C group
Cellular Physiology
The treatment of animals in the IR-C group led to a 0.54-fold decrease in KIM-1 mRNA compared with the animals in the IR-S group, however the reduction was not enough to
Infused BMMCs are recruited to injured kidney hours after infusion and remain for up to 24 h
One of the characteristics of stem cells is their ability to migrate to the injured tissue as a different periods until the end of the experimental protocol, Tc-BMMCs in the S-C and IR-C groups were evaluated 2 and 4 h after infusion. Three-dimensional image reconstruction of the retroperitoneal region depicted the presence of the BMMCs in kidneys and liver in Tc-BMMCs were mostly found in the spleen in the S-C group, whereas the labeled cells in the IR-C group
Damage-associated molecular patterns and their receptors are downregulated after BMMC infusion
the surface density of CD68 (macrophage), and the resultant tubular damage was depicted by measuring HMGB1. CD68 reactive macrophages were present in the interstitial space and glomeruli of IR groups. HMGB1 immunoreactivity was observed in the cytoplasm of tubule cells in the IR-S group and decreased after BMMC infusion (IR-C group). However, HMGB1
BMMCs stimulate proliferation and decrease apoptosis in tubule cells 24 h after IR
early damage in proximal tubule cells, which can endanger the long-term survival of renal expressed as means ± standard error of the mean (n P < 0.05). #Sta-P < 0.05). 
BMMC infusion induces Nrf2 and HO-1 expression after renal IR
To identify whether the Nrf2/HO-1 signaling pathway is involved in the renoprotective effect of BMMCs, we analyzed ischemic renal tissue using a immunohistochemical technique in each group. Immunohistochemical analysis of renal tissues showed that Nrf-2 was present BMMCs led to a 50.38-fold increase in Nrf2 in the nuclei and 11.44-fold increase of HO-1 in
Discussion
In this study, we evaluated the therapeutic effect of BMMCs in kidney IR in rats and in female rats to provoke severe IRI because females have a high tolerance to AKI. Estrogen has a protective role but the mechanism of this protection is not well known [30] . Thus, to achieve tubular injury in females, we conducted experiments using bilateral ischemia for 1 h followed by reperfusion to induce severe tubular injury caused by impairment of bilateral acute renal injury but, changes seen in this model IR are not the same as in the AKI model. The advantage of using the bilateral IRI model is that the total renal mass is affected, and consequently a measurable increase in serum creatinine and blood urea nitrogen, functional parameters seen in AKI patients, is induced [31] . In addition, the use of this model has provided greater understanding of the underlying pathophysiology, such as vascular and evolution. However, little success has been achieved in clinical translation of therapeutic agents found in these animal models.
One of the limiting factors for the translation of this experimental model to humans is that, in humans, AKI is a focal and limited lesion in tubular cells and strongly contrasts with by most experimental models in rodents, where it is observed as an exacerbated injury. Therefore, the clinical relevance of such models, although highly consistent, is limited, and their distribution pattern of injury may be ambiguous. The proximal and distal tubular ischemic lesions can be observed under diverse clinical conditions, possibly with different therapeutic implications [32] .
Here, we demonstrate that in severe IRI in rats, BMMC therapy administered soon after of increased sodium and potassium wasting close to the values found for control animals, suggesting that this therapy attenuates the tubular epithelial injury ( Table 2) . One of the as well as the regulation of the Na and K excretion (Table 2) . It is well known, after ischemic disrupted [33, 34] . Alterations in the actin cytoskeleton impair the epithelial cell architecture, allowing the formation of extracellular vesicles (blebs), dissociation of the cellular junctional complex with subsequent lateral diffusion of membrane lipids, and integral and peripheral membrane proteins with loss of cell polarity [35, 36] . This disruption is caused primarily by basolateral Na /K ATPase 3,4 and a decrease in the carrier levels of Na and K [37, 38] . Models of ischemia in rats show that the early morphological alterations are the loss of the renal brush border, pathological alteration present in all proximal tubule segments within basement membrane denudation, and casts formation in the tubular lumen. In consequence D), consistent with previous reports [42] . Tubular cell apoptosis decreased in IR-C animals, which suggests that BMMCs could be involved in the preservation of tubular cell metabolism, the caspase activation process, and generation of other mediators of kidney damage caused by IRI.
of KIM-1 mRNA and protein in the kidney tissue and KIM-1 immunolocalization. All these assays clearly demonstrated attenuation of tubular injury in the IR-C group compared with this putative epithelial cell-adhesion molecule is upregulated under various conditions in which proximal tubule cells are injured, resulting in their dedifferentiation, and is therefore considered an early sign of damage [43] .
renal IRI. After cell injury, HMGB1, which is involved in DNA organization and transcription regulation, undergoes nuclear-cytoplasmic translocation. Once released into the circulation, responses [44, 45] . In this study, we investigated the role of BMMCs in the regulation of the 4, and RAGE, as well as the HMGB1 molecule, which plays a fundamental role in sustaining stages of damage signal propagation in response to IR [46, 47] . Treatment of human proximal tubular epithelial cells with recombinant human HMGB1 induced alterations in tubular in part by RAGE [48] . Moreover, HMGB1 has a strong effect in the attraction and homing functional rates immediately after transplantation graft [53, 54] . The reduction in HMGB1 renal IRI model. It is known that in IRI, reperfusion causes more damage to the tissue than the ischemic phase [63] . One of the mechanisms involved in reperfusion-induced injury is the production of ROS [64, 65] . ROS are constantly being produced in cells but the presence of antioxidant investigated the role of the nuclear factor, erythroid 2-related factor 2 (Nrf2)/kelch-like ECHassociated protein 1 (keap 1)/heme oxidase-1 (HO-1) system, a major mechanism in the of Nrf2 and HO-1 protein in renal tissue in rats subjected to IRI and treated with BMMCs and has cell protective and proliferative effects [67, 68] . Nrf2 also coordinates the induction of genes encoding antioxidant enzymes. One of them is HO-1, which acts as an antioxidant because it effects of BMMC administration whereby dead tubular cells are rapidly replaced by new ones. The proliferative burst was depicted by the increase in the PCNA index of tubular cells of IR-C animals cell apoptosis, also found here in the IR-C group, corroborates the cytoprotective effect of cell therapy; diminution of the apoptotic levels could have reestablished equilibrium in the kinetics of the tubular compartment. This improvement induced by BMMCs has been already been shown in several acute and chronic models of disease after diverse kinds of cell therapy [13] [14] [15] 71] and seems to be due to the production of pro-survival growth factors [72] [73] [74] .
In the present study, we used the BMMCs because this cell population seems to increase migrated mainly to the kidneys in groups subjected to IRI, albeit in a small amount, suggesting that injured kidney can secrete chemoattraction factors for recruitment of BMMCs, as shown promotes kidney repair in a variety of ways. They demonstrate that MSCs can secrete high levels of growth factors, such as hepatocyte growth factor, insulin-like growth factor-1, and vascular endothelial growth factor. The infusion of conditioned medium from these a role in kidney repair through paracrine rather than endocrine mechanisms. Our results of cells present in the kidney interstitial tissue after 24 h was low, reinforcing the hypothesis of a paracrine mechanism of action. The self-regeneration of renal tubule cells after toxic injury has been described as a natural process due to the presence of resident intrarenal tubular cells [40] . Humphreys et al. [7] reported that, after IR injury, proliferation of renal epithelial cells began after 48 h. Our study showed that there was an increase in cell proliferation in tubular cells 24 h after cell therapy, suggesting acceleration of the repopulation process. In addition, BMMCs had a protective role for morphological changes in kidney tissue caused by IRI, as indicated by model of renal IR. Their results show that endothelial progenitors favored an increase in the microvasculature, which is associated with improvement in renal function.
In conclusion, BMMC therapy in animals with IR led to improvement in renal function and with a cytoprotective effect due to decreased tubular cell death and acceleration of promise for the development of new interventions after kidney transplantation to decrease the deleterious consequences of severe AKI. 
